Learn more about the quest for Igf binding protein 1 and its role in regulating insulin-like growth factor activity. Explore the latest research and discoveries in this field.
|Payment:||Bitcoin, LiteCoin, Zelle, Credit Cards, Western Union, MoneyGram|
|Delivery:||Express (2-5 days), Fedex, DHL|
|Prescription:||OVER THE COUNTER|
|Where to Buy STEROIDS online?||https://max-steroids.com|
Where to Buy Anabolic Steroids Online:
Igf binding protein 1 quest
Popular Questions about Igf binding protein 1 quest:
What is the role of IGFBP-1 in growth and development?
IGFBP-1 plays a crucial role in growth and development by binding to insulin-like growth factors (IGFs) and regulating their availability and activity. It helps to control the levels of IGFs in the bloodstream and tissues, thereby influencing processes such as cell proliferation, differentiation, and tissue growth.
How is IGFBP-1 regulated in the body?
IGFBP-1 is regulated by various factors, including nutritional status, hormones, and growth factors. For example, its expression is stimulated by fasting and low levels of insulin, while it is inhibited by insulin and high levels of glucose. Hormones such as glucocorticoids and growth hormone also play a role in regulating IGFBP-1 levels.
What happens when IGFBP-1 levels are dysregulated?
Dysregulation of IGFBP-1 levels can have significant effects on growth and development. For example, low levels of IGFBP-1 have been associated with conditions such as insulin resistance, obesity, and certain types of cancer. On the other hand, high levels of IGFBP-1 have been linked to conditions such as malnutrition and growth retardation.
Are there any genetic factors that influence IGFBP-1 levels?
Yes, genetic factors can influence IGFBP-1 levels. Certain polymorphisms in the IGFBP-1 gene have been associated with variations in IGFBP-1 levels. For example, some variants of the gene have been linked to lower IGFBP-1 levels, while others have been associated with higher levels.
What are the potential therapeutic applications of targeting IGFBP-1?
Targeting IGFBP-1 could have potential therapeutic applications in various conditions. For example, modulating IGFBP-1 levels could be beneficial in the treatment of insulin resistance, obesity, and cancer. Additionally, understanding the role of IGFBP-1 in growth and development could help in developing therapies for conditions such as growth retardation and malnutrition.
How is IGFBP-1 measured in the body?
IGFBP-1 levels can be measured in various ways. One common method is through immunoassays, which detect and quantify the protein in blood or tissue samples. Other techniques such as Western blotting and ELISA (enzyme-linked immunosorbent assay) can also be used to measure IGFBP-1 levels.
What are the limitations of current research on IGFBP-1?
Current research on IGFBP-1 has some limitations. For example, many studies have focused on its role in specific conditions or populations, limiting the generalizability of the findings. Additionally, more research is needed to fully understand the mechanisms underlying the regulation of IGFBP-1 and its interactions with other factors involved in growth and development.
What are the future directions for research on IGFBP-1?
Future research on IGFBP-1 could explore several areas. For example, further investigation is needed to understand the precise mechanisms by which IGFBP-1 regulates IGFs and influences growth and development. Additionally, studying the genetic factors that influence IGFBP-1 levels could provide insights into individual variations in growth and disease susceptibility. Furthermore, exploring the potential therapeutic applications of targeting IGFBP-1 could lead to the development of new treatment strategies.
What is the role of Igf Binding Protein 1 in growth and development?
Igf Binding Protein 1 plays a crucial role in growth and development by regulating the activity of insulin-like growth factors (IGFs). It binds to IGFs and modulates their availability and activity, thereby controlling their effects on cell growth, differentiation, and metabolism.
How is Igf Binding Protein 1 regulated in the body?
Igf Binding Protein 1 is regulated by various factors, including nutritional status, hormones, and growth factors. Insulin is a key regulator of Igf Binding Protein 1, as its levels decrease during fasting or low energy states, leading to an increase in Igf Binding Protein 1 production. Other hormones, such as growth hormone and glucocorticoids, also influence the production and activity of Igf Binding Protein 1.
What happens when Igf Binding Protein 1 levels are altered?
Changes in Igf Binding Protein 1 levels can have significant effects on growth and development. Low levels of Igf Binding Protein 1 are associated with increased IGF activity, which can lead to excessive cell growth and proliferation, as well as metabolic abnormalities. On the other hand, high levels of Igf Binding Protein 1 can reduce IGF activity, resulting in growth retardation and impaired tissue repair.
How to order steroids online?
The Quest for Igf Binding Protein 1: Unraveling Its Role in Growth and Development
In the world of growth and development, there are many molecules that play crucial roles in regulating the processes that shape our bodies. One such molecule is Igf Binding Protein 1 (IGFBP-1), a key player in the insulin-like growth factor (IGF) system. IGFBP-1 is a protein that binds to IGF-1, a hormone that promotes cell growth and division.
For many years, scientists have been intrigued by the role of IGFBP-1 in growth and development. They have sought to understand how this protein functions and how it contributes to the intricate processes that occur during embryonic development, childhood growth, and tissue repair.
Recent research has shed light on the diverse functions of IGFBP-1. It has been found that this protein not only binds to IGF-1, but also regulates its availability and activity. IGFBP-1 can either enhance or inhibit the actions of IGF-1, depending on the context. This suggests that IGFBP-1 acts as a modulator, fine-tuning the effects of IGF-1 in different tissues and at different stages of development.
Understanding the role of IGFBP-1 is crucial for unraveling the complex mechanisms that govern growth and development. By deciphering the functions of this protein, scientists hope to gain insights into various physiological processes, such as bone growth, muscle development, and tissue repair. This knowledge could have implications for the treatment of growth disorders, age-related conditions, and diseases characterized by abnormal cell growth. The quest for IGFBP-1 continues, as scientists strive to uncover its secrets and harness its potential for improving human health.
Importance of Igf Binding Protein 1 in Growth
Igf Binding Protein 1 (IGFBP-1) is a crucial component in the regulation of growth and development in organisms. It plays a significant role in modulating the activity of Insulin-like Growth Factors (IGFs), which are essential for normal growth and development.
1. Regulation of IGF bioavailability:
IGFBP-1 binds to IGFs, specifically IGF-1 and IGF-2, and modulates their bioavailability. It acts as a carrier protein, prolonging the half-life of IGFs and protecting them from degradation. This regulation is critical for maintaining optimal IGF levels in the body, as excessive or insufficient IGF bioavailability can lead to abnormal growth patterns.
2. Control of growth hormone (GH) actions:
IGFBP-1 also plays a role in regulating the actions of Growth Hormone (GH). GH stimulates the production of IGFs, and IGFBP-1 acts as a feedback mechanism by binding to IGFs and inhibiting GH actions. This regulation ensures a balanced and controlled growth process.
3. Impact on fetal growth:
During fetal development, IGFBP-1 is produced by the liver and acts as a major regulator of fetal growth. It binds to IGFs and helps control their availability, ensuring proper growth and development of the fetus. Disruptions in IGFBP-1 production or function can lead to growth abnormalities and developmental disorders.
4. Role in metabolic regulation:
IGFBP-1 is also involved in metabolic regulation, particularly in the control of glucose homeostasis. It is known to inhibit insulin actions and promote glucose production in the liver. This function is important for maintaining stable blood glucose levels and preventing metabolic imbalances.
5. Implications in disease:
Alterations in IGFBP-1 levels or function have been associated with various diseases and conditions. Low levels of IGFBP-1 have been linked to insulin resistance, obesity, and type 2 diabetes. On the other hand, elevated levels of IGFBP-1 have been observed in certain cancers, such as hepatocellular carcinoma. Understanding the role of IGFBP-1 in these diseases can provide insights into their pathogenesis and potential therapeutic targets.
In conclusion, Igf Binding Protein 1 plays a crucial role in growth and development. Its regulation of IGF bioavailability, control of GH actions, impact on fetal growth, involvement in metabolic regulation, and implications in disease highlight its significance in maintaining normal growth processes and overall health.
The Mechanism of Igf Binding Protein 1
Igf Binding Protein 1 (IGFBP-1) is a key player in the regulation of insulin-like growth factor (IGF) signaling and is involved in various physiological processes, including growth and development. Understanding the mechanism of IGFBP-1 is crucial for unraveling its role in these processes.
Binding to IGFs
One of the main functions of IGFBP-1 is to bind to IGFs and regulate their availability and activity. IGFBP-1 has a high affinity for IGFs and can bind to both IGF-1 and IGF-2. This binding prevents the interaction of IGFs with their receptors, thereby inhibiting their signaling pathways.
IGFBP-1 binds to IGFs in a specific manner. It has been found that IGFBP-1 has multiple binding sites for IGFs, including a high-affinity binding site and several lower-affinity binding sites. The high-affinity binding site is responsible for the initial binding of IGFBP-1 to IGFs, while the lower-affinity binding sites contribute to the stability of the IGFBP-1-IGF complex.
Regulation of IGF Availability
IGFBP-1 plays a crucial role in regulating the availability of IGFs in the circulation. It is produced and secreted by the liver in response to various physiological and pathological stimuli, such as fasting, stress, and inflammation. The secretion of IGFBP-1 is tightly regulated by hormonal and nutritional factors, including insulin, glucagon, and growth hormone.
When IGFBP-1 binds to IGFs, it forms a complex that is too large to cross the capillary walls, thereby preventing the IGFs from reaching their target tissues. This sequestration of IGFs by IGFBP-1 helps to regulate their availability and ensures that they are delivered to the appropriate tissues at the right time.
Interaction with Other Proteins
In addition to binding to IGFs, IGFBP-1 can interact with other proteins, further modulating its function. For example, IGFBP-1 can bind to extracellular matrix proteins, such as collagen and fibronectin, which can enhance its stability and protect it from degradation.
IGFBP-1 can also interact with other IGFBPs and IGF receptors, forming ternary complexes that can affect the bioavailability and activity of IGFs. These interactions add another layer of complexity to the regulation of IGF signaling and highlight the importance of IGFBP-1 in this process.
The mechanism of IGFBP-1 involves its binding to IGFs, regulation of IGF availability, and interaction with other proteins. By understanding the intricacies of this mechanism, we can gain insights into the role of IGFBP-1 in growth and development and potentially develop therapeutic strategies to target this pathway.
Regulation of Igf Binding Protein 1 Expression
The expression of Igf Binding Protein 1 (IGFBP-1) is tightly regulated in order to maintain proper growth and development. Several factors have been identified that influence the expression of IGFBP-1, including hormonal regulation, nutritional status, and developmental stage.
IGFBP-1 expression is primarily regulated by hormones, particularly insulin-like growth factor 1 (IGF-1) and insulin. IGF-1 is a key regulator of growth and development, and its levels in the body fluctuate in response to various stimuli. When IGF-1 levels are high, such as during periods of growth, IGFBP-1 expression is typically suppressed. Conversely, when IGF-1 levels are low, such as during fasting or in certain disease states, IGFBP-1 expression is often upregulated.
Insulin, a hormone that regulates blood sugar levels, also plays a role in the regulation of IGFBP-1 expression. Insulin inhibits the expression of IGFBP-1, and its levels are inversely correlated with IGFBP-1 expression. During fasting or in conditions of insulin resistance, when insulin levels are low, IGFBP-1 expression is typically increased.
The nutritional status of an individual also influences IGFBP-1 expression. Fasting or a low-calorie diet has been shown to increase IGFBP-1 expression, while a high-calorie diet or overfeeding can suppress its expression. This suggests that IGFBP-1 may play a role in regulating energy balance and metabolism.
IGFBP-1 expression is developmentally regulated, with different patterns of expression observed at different stages of growth and development. During fetal development, IGFBP-1 is expressed in various tissues and plays a role in regulating fetal growth. In adults, IGFBP-1 expression is primarily observed in the liver, where it is thought to play a role in regulating IGF-1 availability.
Overall, the regulation of IGFBP-1 expression is complex and involves multiple factors. Further research is needed to fully understand the mechanisms underlying the regulation of IGFBP-1 and its role in growth and development.
Igf Binding Protein 1 and Insulin Resistance
Insulin resistance is a condition in which the body’s cells become less responsive to the effects of insulin, resulting in elevated blood glucose levels. This condition is often associated with the development of type 2 diabetes and other metabolic disorders.
Research has shown that Igf Binding Protein 1 (IGFBP-1) may play a role in the development of insulin resistance. IGFBP-1 is a protein that binds to insulin-like growth factors (IGFs) and regulates their activity in the body. It is primarily produced by the liver and its levels are influenced by various factors, including nutritional status and hormonal signals.
Regulation of IGFBP-1 and Insulin Resistance
IGFBP-1 levels are known to be inversely correlated with insulin levels in the body. When insulin levels are high, such as after a meal, IGFBP-1 production is suppressed. On the other hand, when insulin levels are low, such as during fasting or in individuals with insulin resistance, IGFBP-1 production is increased.
This inverse relationship between IGFBP-1 and insulin levels suggests that IGFBP-1 may be involved in the development of insulin resistance. Studies have shown that elevated levels of IGFBP-1 are associated with insulin resistance and may contribute to the impaired glucose metabolism seen in this condition.
There are several mechanisms through which IGFBP-1 may contribute to insulin resistance. One possibility is that IGFBP-1 may interfere with the action of insulin by binding to IGFs and preventing them from interacting with their receptors. This could lead to reduced insulin signaling and impaired glucose uptake by cells.
Additionally, IGFBP-1 has been shown to inhibit the production of insulin receptors in certain cell types. This could further contribute to insulin resistance by reducing the number of available receptors for insulin to bind to.
Overall, the role of IGFBP-1 in insulin resistance is complex and multifaceted. While elevated levels of IGFBP-1 have been associated with insulin resistance, further research is needed to fully understand the underlying mechanisms and potential therapeutic implications.
Understanding the relationship between IGFBP-1 and insulin resistance may provide new insights into the development and treatment of metabolic disorders, such as type 2 diabetes. Future studies should focus on elucidating the specific mechanisms through which IGFBP-1 influences insulin action and exploring potential strategies to modulate its activity for therapeutic benefit.
Igf Binding Protein 1 and Cancer
Cancer is a complex and multifaceted disease that involves uncontrolled cell growth and proliferation. It is characterized by the ability of cancer cells to evade normal regulatory mechanisms and invade surrounding tissues. Research has shown that Igf Binding Protein 1 (IGFBP-1) may play a role in the development and progression of cancer.
1. Regulation of Igf Signaling
IGFBP-1 is a key regulator of insulin-like growth factor (IGF) signaling, which plays a critical role in cell growth, proliferation, and survival. IGFBP-1 binds to IGFs and modulates their availability and activity. In cancer, dysregulation of IGFBP-1 expression and function can lead to aberrant IGF signaling, promoting tumor growth and metastasis.
2. Tumor Suppressor Activity
Studies have suggested that IGFBP-1 may have tumor suppressor activity. It has been found to inhibit cell proliferation, induce apoptosis, and suppress angiogenesis in various cancer types. Additionally, IGFBP-1 has been shown to inhibit the activity of several oncogenic signaling pathways, including the PI3K/AKT and MAPK pathways, which are commonly dysregulated in cancer.
3. Prognostic Marker
IGFBP-1 has also been investigated as a potential prognostic marker in cancer. Research has shown that low levels of IGFBP-1 expression are associated with poor prognosis in various cancer types, including breast, ovarian, and colorectal cancer. Furthermore, IGFBP-1 expression has been found to correlate with tumor stage, grade, and response to therapy, suggesting its potential as a predictive biomarker.
4. Therapeutic Target
The dysregulation of IGFBP-1 in cancer makes it an attractive therapeutic target. Strategies aimed at restoring or enhancing IGFBP-1 expression and function have shown promise in preclinical studies. For example, the use of small molecules or gene therapy to upregulate IGFBP-1 expression has been shown to inhibit tumor growth and sensitize cancer cells to chemotherapy.
Overall, the role of IGFBP-1 in cancer is complex and context-dependent. While it may have tumor suppressor activity in some contexts, it can also promote tumor growth and metastasis in others. Further research is needed to better understand the mechanisms underlying the role of IGFBP-1 in cancer and to explore its potential as a therapeutic target and prognostic marker.
Igf Binding Protein 1 and Diabetes
Diabetes is a chronic metabolic disorder characterized by high blood sugar levels. It is a complex disease that can have various causes and impacts multiple organs and systems in the body. One of the key factors in the development and progression of diabetes is insulin resistance, which occurs when the body’s cells become less responsive to the effects of insulin.
Igf Binding Protein 1 (IGFBP-1) has been found to play a significant role in the regulation of glucose metabolism and insulin sensitivity. IGFBP-1 is a protein that binds to insulin-like growth factors (IGFs) and modulates their actions. It is primarily produced in the liver and is regulated by various factors, including nutritional status, hormones, and growth factors.
Role of IGFBP-1 in Diabetes
Studies have shown that IGFBP-1 levels are altered in individuals with diabetes. In individuals with type 2 diabetes, IGFBP-1 levels are often reduced, which may contribute to the development of insulin resistance. IGFBP-1 has been found to enhance insulin sensitivity by inhibiting the actions of IGF-1, which can promote insulin resistance when present in excess.
Moreover, IGFBP-1 has been shown to regulate glucose production in the liver. It inhibits the release of glucose from the liver, a process known as gluconeogenesis, which is increased in individuals with diabetes. By reducing gluconeogenesis, IGFBP-1 helps to maintain normal blood sugar levels.
Potential Therapeutic Implications
The role of IGFBP-1 in diabetes suggests that it may be a potential therapeutic target for the treatment of the disease. Strategies that aim to increase IGFBP-1 levels or enhance its actions could help improve insulin sensitivity and regulate glucose metabolism.
Several approaches have been explored to modulate IGFBP-1 levels, including pharmacological interventions and lifestyle modifications. For example, certain medications, such as metformin, have been shown to increase IGFBP-1 levels in individuals with diabetes. Additionally, lifestyle modifications, such as exercise and dietary changes, have been found to positively impact IGFBP-1 levels.
Igf Binding Protein 1 plays a crucial role in the regulation of glucose metabolism and insulin sensitivity. Altered IGFBP-1 levels have been observed in individuals with diabetes, suggesting its involvement in the pathogenesis of the disease. Further research is needed to fully understand the mechanisms underlying the relationship between IGFBP-1 and diabetes and to explore its potential as a therapeutic target.
Igf Binding Protein 1 and Aging
Igf Binding Protein 1 (IGFBP-1) has been a subject of interest in the field of aging research due to its potential role in the aging process. IGFBP-1 is a protein that binds to insulin-like growth factors (IGFs) and regulates their bioavailability and activity. It has been suggested that IGFBP-1 may play a role in modulating the effects of IGFs on aging and age-related diseases.
Decreased IGFBP-1 Levels with Age
One of the key observations in studying IGFBP-1 and aging is the decrease in IGFBP-1 levels with age. Several studies have shown that circulating levels of IGFBP-1 tend to decline with increasing age. This decline in IGFBP-1 levels may have implications for the aging process, as it can lead to increased IGF bioavailability and activity.
Implications for Aging and Age-Related Diseases
The decrease in IGFBP-1 levels with age may have important implications for aging and age-related diseases. IGFs play a crucial role in growth and development, but they have also been implicated in the aging process and age-related diseases such as cancer, cardiovascular disease, and neurodegenerative disorders. The decrease in IGFBP-1 levels may result in increased IGF signaling, which can contribute to the development and progression of these diseases.
Potential Therapeutic Target
Given the potential role of IGFBP-1 in aging and age-related diseases, it has been suggested that targeting IGFBP-1 could be a potential therapeutic strategy. By modulating IGFBP-1 levels or activity, it may be possible to regulate IGF signaling and potentially slow down the aging process or prevent age-related diseases. However, further research is needed to fully understand the mechanisms underlying the relationship between IGFBP-1 and aging before therapeutic interventions can be developed.
In summary, IGFBP-1 is a protein that plays a role in regulating IGF bioavailability and activity. The decrease in IGFBP-1 levels with age may have implications for the aging process and age-related diseases. Understanding the role of IGFBP-1 in aging could potentially lead to the development of therapeutic interventions to slow down the aging process or prevent age-related diseases. Further research is needed to fully unravel the complex relationship between IGFBP-1 and aging.
Potential Therapeutic Applications of Igf Binding Protein 1
Igf Binding Protein 1 (IGFBP-1) has been the subject of extensive research due to its role in growth and development. In addition to its physiological functions, IGFBP-1 has shown potential therapeutic applications in various medical conditions.
IGFBP-1 has been found to play a role in glucose homeostasis and insulin sensitivity. Studies have shown that IGFBP-1 levels are inversely correlated with insulin resistance, suggesting that increasing IGFBP-1 levels could be beneficial for individuals with diabetes. Therapeutic interventions aimed at increasing IGFBP-1 expression or activity could potentially improve glucose control and insulin sensitivity in diabetic patients.
IGFBP-1 has been implicated in the regulation of cell proliferation and apoptosis, making it a potential target for cancer therapy. Studies have shown that IGFBP-1 can inhibit the growth of various cancer cell lines, including breast, prostate, and colon cancer. Furthermore, IGFBP-1 has been found to sensitize cancer cells to chemotherapy drugs, suggesting that it could be used in combination with existing cancer treatments to enhance their efficacy.
3. Cardiovascular Disease
IGFBP-1 has been shown to have anti-inflammatory and anti-atherogenic effects, making it a potential therapeutic target for cardiovascular disease. Studies have demonstrated that IGFBP-1 can inhibit the migration and proliferation of vascular smooth muscle cells, which are key contributors to the development of atherosclerosis. Additionally, IGFBP-1 has been found to reduce inflammation in the arterial wall, further highlighting its potential as a therapeutic agent for cardiovascular disease.
IGFBP-1 has been implicated in the regulation of aging and age-related diseases. Studies have shown that IGFBP-1 levels decrease with age, and low levels of IGFBP-1 have been associated with age-related conditions such as sarcopenia and osteoporosis. Therapeutic interventions aimed at increasing IGFBP-1 levels could potentially delay the onset of age-related diseases and improve overall health and longevity in aging populations.
In conclusion, Igf Binding Protein 1 (IGFBP-1) has shown promising potential as a therapeutic target in various medical conditions. Further research is needed to fully understand the mechanisms underlying its therapeutic effects and to develop targeted interventions for specific diseases.
Future Directions in Igf Binding Protein 1 Research
As our understanding of Igf Binding Protein 1 (IGFBP-1) continues to grow, there are several important areas of research that warrant further investigation. These future directions will help to shed light on the role of IGFBP-1 in growth and development, and may have important implications for the treatment of various diseases and conditions.
1. Mechanisms of IGFBP-1 Regulation
One important area of future research is the investigation of the mechanisms that regulate IGFBP-1 expression and activity. Understanding how IGFBP-1 levels are controlled at the molecular level will provide valuable insights into the factors that influence growth and development. This research could also lead to the development of novel therapeutic strategies for conditions associated with abnormal IGFBP-1 regulation.
2. Interactions with Other Proteins
Another important area of investigation is the study of IGFBP-1’s interactions with other proteins. IGFBP-1 is known to interact with several other proteins, including insulin-like growth factors (IGFs) and insulin. Further research is needed to elucidate the specific binding partners and the functional consequences of these interactions. This knowledge could help to uncover new pathways and mechanisms involved in growth regulation.
3. Role of IGFBP-1 in Disease
Exploring the role of IGFBP-1 in various diseases and conditions is another promising avenue for future research. IGFBP-1 has been implicated in the pathogenesis of several diseases, including diabetes, cancer, and cardiovascular disease. Investigating the mechanisms by which IGFBP-1 contributes to these conditions could provide important insights into their underlying biology and potentially lead to the development of targeted therapies.
4. Development of IGFBP-1 Modulators
Given the potential therapeutic implications of IGFBP-1, there is a need for the development of modulators that can selectively regulate its activity. These modulators could be used to either enhance or inhibit IGFBP-1 function, depending on the specific disease or condition being targeted. Future research should focus on identifying and characterizing molecules that can modulate IGFBP-1 activity, with the goal of eventually translating these findings into clinical applications.
5. Clinical Studies
Finally, conducting clinical studies to further investigate the role of IGFBP-1 in human health and disease is essential. These studies could involve analyzing IGFBP-1 levels in patient samples, correlating these levels with clinical outcomes, and assessing the effects of manipulating IGFBP-1 levels in various disease models. This research will provide valuable insights into the potential diagnostic and therapeutic applications of targeting IGFBP-1.
In conclusion, future research in the field of IGFBP-1 should focus on elucidating the mechanisms of regulation, understanding interactions with other proteins, exploring its role in disease, developing modulators, and conducting clinical studies. These endeavors will help to unravel the complex role of IGFBP-1 in growth and development, and may ultimately lead to improved treatments for a variety of conditions.
Blum WF, Ranke MB, Kietzmann K, Gauggel E, Zeisel HJ, Bierich JR, et al. A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency. J Clin Endocrinol Metab. 1990;70(5):1292-8.
Daughaday WH, Hall K, Raben MS, Salmon WD Jr, van den Brande JL, van Wyk JJ. Somatomedin: proposed designation for sulfation factor. Nature. 1972;235(5333):107-9.
De Pablo F, De La Rosa EJ, De La Rosa VJ. Insulin-like growth factor binding protein-1 in development and disease. Int J Dev Biol. 1995;39(5):791-801.
Lee PD, Giudice LC, Conover CA, Powell DR. Insulin-like growth factor binding protein-1: recent findings and new directions. Proc Soc Exp Biol Med. 1997;216(3):319-57.
Oh Y, Muller HL, Lamson G, Rosenfeld RG. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition. J Biol Chem. 1993;268(19):14964-71.
Phillips LS, Loriaux DL, Sherins RJ, Cutler GB Jr. Insulin-like growth factor-I (IGF-I), IGF-II, and somatomedin activity in the evaluation of growth hormone secretion. J Clin Endocrinol Metab. 1982;55(4):774-9.
Rajaram S, Baylink DJ, Mohan S. Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev. 1997;18(6):801-31.
Rosenfeld RG, Hwa V, Wilson E, Plymate S, Oh Y. The insulin-like growth factor-binding protein superfamily. Growth Horm IGF Res. 2000;10 Suppl B:S16-7.
Yakar S, Rosen CJ, Beamer WG, Ackert-Bicknell CL, Wu Y, Liu JL, et al. Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest. 2002;110(6):771-81.